Conversely, lingering downregulation of StarD5 with prolonged lipid-cholesterol excess accelerates fatty liver’s transition to fibrosis; mediated via dysregulation in the oxysterol signaling pathway. The gene discussed is STARD5; the disease is Hepatic steatosis.